WallStSmart
RANI

Rani Therapeutics Holdings Inc

NASDAQ: RANI · HEALTHCARE · BIOTECHNOLOGY

$1.11
+2.03% today

Updated 2026-06-03

Market cap
$107.58M
P/E ratio
P/S ratio
33.95x
EPS (TTM)
$-0.27
Dividend yield
52W range
$0 – $4
Volume
1.2M

Rani Therapeutics Holdings Inc (RANI) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item2019202020212022202320242025
Total assets$23.02M$79.42M$124.21M$108.03M$57.92M$36.63M$58.62M
Cash & equivalents$16.54M$73.06M$117.45M$27.01M$5.86M$3.76M$18.62M
Current assets$16.94M$74.94M$119.59M$100.92M$50.85M$29.74M$53.32M
Total liabilities$119.66M$192.75M$2.64M$34.02M$32.47M$33.14M$17.11M
Current liabilities$3.50M$5.31M$2.64M$4.82M$7.99M$19.89M$12.67M
Long-term debt$2.41M$29.15M$24.48M$9.61M
Shareholder equity$-96.64M$-113.34M$47.41M$36.85M$12.87M$1.99M$33.01M
Retained earnings$-97.30M$-114.00M$-8.33M$-38.92M$-72.89M$-102.91M$-132.58M
Accounts receivable$250000.00$1.72M$200000.00$428000.00$2.04M
Inventory$1.00
Goodwill

Frequently asked questions

What is Rani Therapeutics Holdings Inc's revenue?

Rani Therapeutics Holdings Inc's trailing twelve-month revenue is $3.17M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is RANI?

In its most recent fiscal year, RANI ran a gross margin of 44.89%, an operating margin of -2,345.99%, and a net margin of -1,817.09%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does RANI generate?

RANI produced $-18.80M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is RANI's balance sheet healthy?

RANI holds $18.62M in cash and equivalents against — in long-term debt, on $33.01M of shareholder equity. That debt is best read against the cash flow the business throws off each year.